These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 2516809

  • 1. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA.
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monoclonal gammopathy of undetermined significance (MGUS).
    Kyle RA.
    Baillieres Clin Haematol; 1995 Dec; 8(4):761-81. PubMed ID: 8845571
    [Abstract] [Full Text] [Related]

  • 5. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Kyle RA, Rajkumar SV.
    Oncology (Williston Park); 2011 Jun; 25(7):578-86. PubMed ID: 21888255
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does my patient with a serum monoclonal spike have multiple myeloma?
    Bianchi G, Ghobrial IM.
    Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J.
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
    Eythorsson E, Rognvaldsson S, Thorsteinsdottir S, Einarsson Long T, Reed ER, Sigurdardottir GA, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Olafsson I, Thorsteinsdottir I, Sveinsdottir SV, Sigurdsson F, Thordardottir AR, Palsson R, Indridason OS, Jonsson A, Gislason GK, Olafsson A, Sigurdsson J, Steingrimsdottir H, Hultcrantz M, Durie BGM, Harding S, Landgren O, Aspelund T, Love TJ, Kristinsson SY.
    Ann Intern Med; 2024 Apr; 177(4):449-457. PubMed ID: 38560901
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal Gammopathy of Undetermined Significance.
    Gonsalves WI, Rajkumar SV.
    Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
    [Abstract] [Full Text] [Related]

  • 12. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
    Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E, Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group.
    Br J Haematol; 2009 Oct; 147(1):22-42. PubMed ID: 19673884
    [No Abstract] [Full Text] [Related]

  • 13. [Benign monoclonal gammopathy].
    Shirota T, Kondo M, Uchida H, Ito H.
    Nihon Rinsho; 1995 Mar; 53(3):720-4. PubMed ID: 7699912
    [Abstract] [Full Text] [Related]

  • 14. Differential diagnosis of monoclonal gammopathy.
    Gandara DR, Mackenzie MR.
    Med Clin North Am; 1988 Sep; 72(5):1155-67. PubMed ID: 3137401
    [Abstract] [Full Text] [Related]

  • 15. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S.
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal gammopathy and multiple myeloma in the elderly.
    Kyle RA.
    Baillieres Clin Haematol; 1987 Jun; 1(2):533-57. PubMed ID: 3322448
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 18. [Monoclonal gammopathies of undetermined significance called "MGUS"].
    Clément F.
    Schweiz Med Wochenschr; 1989 Jul 11; 119(27-28):970-8. PubMed ID: 2508215
    [Abstract] [Full Text] [Related]

  • 19. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.
    Goyal G, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa YL, Fonder AL, Hobbs MA, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Gonsalves WI, Kourelis TV, Warsame R, Kyle RA, Kumar SK.
    Leukemia; 2019 May 11; 33(5):1273-1277. PubMed ID: 30787429
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, Rajkumar SV.
    Hematol Oncol Clin North Am; 2007 Dec 11; 21(6):1093-113, ix. PubMed ID: 17996590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.